A S X A N N O U N C E M E N T 2 9 O c t o b e r 2 0 2 6 Quarterly Activities Report and Appendix 4C Vectus Biosystems Limited (ASX:VBS) (Vectus or the Company) is pleased to present its Quarterly Activities Report and Quarterly Cash Flow Report – Appendix 4C for the period ended 30 September...
Quarterly Activities & Appendix 4C Cash Flow Reports
Filed with ASX ·
6ix is reading this filing.
Vectus Biosystems Limited on 6ix
In the deck
Story so far
Earlier from Vectus Biosystems
- FDA Pre-IND Meeting Request Granted for VB0004
- Placement of Shares
- Appointment of Dr Tara Speranza as CEO & CTO
- VB4-P5 Renal Compound Transaction Settled
- Half Year Report & Appendix 4D
Follow Vectus Biosystems into a list and get an email when it puts out news.
Follow Vectus Biosystems